Parity History Determines a Systemic Inflammatory Response to Spread of Ovarian Cancer in Naturally Aged Mice Urzua Ulises 1, 4, 5 ;Chacon Carlos 1 ;Lizama.

Slides:

Advertisements

Similar presentations

Promoting Neurovascular Recovery in Aged Mice after Ischemic Stroke - Prophylactic Effect of Omega-3 Polyunsaturated Fatty Acids Cai Mengfei 1 ;Zhang Wenting.

Advertisements

Parity History Determines a Systemic Inflammatory Response to Spread of Ovarian Cancer in Naturally Aged Mice Urzua Ulises 1, 4, 5 ;Chacon Carlos 1 ;Lizama.

Allergy and Aging: An Old/New Emerging Health Issue

Figure S3. Absence of DNA methylation in pre-cancerous thymocytes

Peng Fangyu 1, 2 ;Xie Fang 1 ;Muzik Otto 3, 4 ;

Promoting Neurovascular Recovery in Aged Mice after Ischemic Stroke - Prophylactic Effect of Omega-3 Polyunsaturated Fatty Acids Cai Mengfei 1 ;Zhang Wenting.

Prognosis of younger patients in non-small cell lung cancer

The involvement of BDNF, NGF and GDNF in aging and Alzheimer#cod#x00027;s disease Josiane Budni ;Tatiani Bellettini-Santos;Francielle Mina;Michelle Lima.

Parity History Determines a Systemic Inflammatory Response to Spread of Ovarian Cancer in Naturally Aged Mice Urzua Ulises 1, 4, 5 ;Chacon Carlos 1 ;Lizama.

Volume 19, Issue 5, Pages (May 2017)

Volume 13, Issue 5, Pages (November 2015)

Chen Yali;Yin Mengmei;Cao Xuejin;Hu Gang;Xiao Ming;

Chen Yali;Yin Mengmei;Cao Xuejin;Hu Gang;Xiao Ming;

Chen Yali;Yin Mengmei;Cao Xuejin;Hu Gang;Xiao Ming;

Chen Yali;Yin Mengmei;Cao Xuejin;Hu Gang;Xiao Ming;

LMNA -mutated Rabbits: A Model of Premature Aging Syndrome with Muscular Dystrophy and Dilated Cardiomyopathy Sui Tingting 1 ;Liu Di 1 ;Liu Tingjun 1 ;Deng.

Antitumor effect of the combination of IL-2 IC and anti–CTLA-4.

Attema et al., Supplementary Figure 1

MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma Liver Cancer 2017;6: DOI: /

Lack of Evidence From a Transgenic Mouse Model that the Activation and Migration of Melanocytes to the Epidermis after Neonatal UVR Enhances Melanoma.

Molecular Therapy - Oncolytics

MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice by Stephanie Grabow, Alex R. D. Delbridge,

Frank D’Ovidio, MD, Marco Mura, MD, Melanie Tsang, MSc, Thomas K

Defining Resistance and Tolerance to Cancer

Fig. 8. In vivo suppression of MM by CMLD

BV6 increases tumor burden in bone.

Fig. 6. Increased efficacy of immunotherapy in lymphangiogenic B16 melanomas depends on CCR7 signaling before therapy and local activation and expansion.

Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non–Small Cell Lung Cancer Junghoon Shin, MD, Bhumsuk Keam, MD, PhD, Miso.

Takeshi Isobe, MD, PhD, Amir Onn, MD, Daniel Morgensztern, MD, Jörg J

Young Aged Isochronic Heterochronic Isochronic Heterochronic

Fig. 4. Antitumor efficacy of ERY974 against various cancer types.

Antitumor effect of local cancer immunotherapy treatment toward distant B16F10 tumors. Antitumor effect of local cancer immunotherapy treatment toward.

Lukkana Suksanpaisan, Rong Xu, Mulu Z

Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive.

Volume 16, Issue 11, Pages (September 2016)

Kaplan-Meier curves for overall survival (OS) probability.

Molecular Therapy - Methods & Clinical Development

Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma Alessandra Lopes, Kevin Vanvarenberg, Véronique Préat,

Yoshiaki Yamaguchi, Hitoshi Okamura

Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes

Volume 17, Issue 5, Pages (March 2007)

Volume 15, Issue 3, Pages (March 2009)

Fig. 7. mRIPO therapy restricts tumor growth and produces antigen-specific antitumor immunity. mRIPO therapy restricts tumor growth and produces antigen-specific.

Fig. 3 Agonists of innate immunity are effective only when released locally from the hydrogel. Agonists of innate immunity are effective only when released.

Anti-CD96 combines with anti–CTLA-4 or anti–PD-1 to suppress experimental and spontaneous lung metastases. Anti-CD96 combines with anti–CTLA-4 or anti–PD-1.

Effects of tumour size on response to treatment in the KPC model.

Mouse lymphoma model. Mouse lymphoma model. A, EL-Arf−/− cells (1 × 106) were tail-vein injected into C57BL/6 mice. LNIWC imaging was separated into 2.

A ID8 scr sh cx2 cx3 cx6 B C Supplementary Figure 4. The fractalkine axis does not regulate ascites formation.

MRP2 inhibition mitigates pulmonary burden and bacteremia following lung challenge with S. pneumoniae. MRP2 inhibition mitigates pulmonary burden and bacteremia.

Volume 13, Issue 5, Pages (November 2015)

Supplementary figure 1 A B Water (Control) Pre-alcohol Post-alcohol

Mice immunized twice with RRBC showed superior protection to tumor challenge with αGal-positive MC38 colon carcinoma cells compared with mock-immunized.

CD8 T cells play a critical role in responses of TILs due to BRAF inhibition. CD8 T cells play a critical role in responses of TILs due to BRAF inhibition.

Anti-Flk-1 treatment inhibits growth of s. c. 4T1 and B16 tumors. s. c

Effect of therapy with S247 on the development of liver metastases after 14 and 21 days of tumor growth. Effect of therapy with S247 on the development.

Endothelial cells/microvasucles are increased in prostate cancer versus normal tissues. Endothelial cells/microvasucles are increased in prostate cancer.

Induction of a tumor-specific immune response following radiofrequency ablation (RFA). Induction of a tumor-specific immune response following radiofrequency.

Efficacy of DC therapy is synergistically enhanced by combination therapy with TAM depletion in mesothelioma mouse models. Efficacy of DC therapy is synergistically.

CD44 depletion blocks tumor cell aggregation and lung metastasis in vivo. CD44 depletion blocks tumor cell aggregation and lung metastasis in vivo. A,

In vivo bioluminescence imaging of primary tumors and tumor metastasis

A to C, MetMAb shows strong antitumor activity in the KP4 orthotopic model of pancreatic cancer by ultrasound. A to C, MetMAb shows strong antitumor activity.

Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes

Intraperitoneal or intratumoral injection of 6-thio-dG or 6-thioguanine. Intraperitoneal or intratumoral injection of 6-thio-dG or 6-thioguanine. A, 2.

Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors. Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors.

Transgenic mice with constitutively active NIK show increased tumor growth in bone. Transgenic mice with constitutively active NIK show increased tumor.

BV6 increases bone metastasis.

Identification of a subpopulation of highly metastatic pancreatic cancer cells. Identification of a subpopulation of highly metastatic pancreatic cancer.

In vivo shRNA screening strategy.

Depletion of CD8+, CD4+, and Ly6G+ cells in subcutaneous TUBO tumor-bearing BALB/c mice treated with KM100 + MTX. Depletions were conducted by intraperitoneal.

DHA and dietary n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in xenograft models. DHA and dietary n-3 PUFAs inhibit endometrial cancer.

Presentation transcript:

Parity History Determines a Systemic Inflammatory Response to Spread of Ovarian Cancer in Naturally Aged Mice Urzua Ulises 1, 4, 5 ;Chacon Carlos 1 ;Lizama Luis 2 ;Sarmiento Sebasti#cod#x000E1;n 1 ;Villalobos P#cod#x000ED;a 1 ;Kroxato Bel#cod#x000E9;n 1 ;Marcelain Katherine 3, 5 ;Gonzalez Mar#cod#x000ED;a-Julieta 4 ; 1 Laboratorio de Gen#cod#x000F3;mica Aplicada, Facultad de Medicina, Universidad de Chile ; 2 Programa de Virolog#cod#x000ED;a, ICBM ; 3 Programa de Gen#cod#x000E9;tica Humana, ICBM ; 4 Programa de Biolog#cod#x000ED;a Celular y Molecular, ICBM ; 5 Departamento de Oncolog#cod#x000ED;a B#cod#x000E1;sica y Cl#cod#x000ED;nica, Facultad de Medicina, Universidad de Chile, Santiago, Chile. ; Figure 4. Tumor spread and survival of host aged mice. A Demonstrative image of intraperitoneal tumor implants formed in a 19 months-old virgin C57BL6 female mouse injected with MOSE cells. Tumor implants in the omental fat band are shown pulled-out with clamps. B Survival plots of virgin and multiparous aged mice injected with IG-10 MOSE cells; day 0 corresponds to 16.1 #cod#x000B1; 0.3 months of age for the two groups. Median survivals were 98 and 87 days for the multiparous and virgin groups, respectively. The p value of log-rank Mantel-Cox is shown. Both the log-rank and the Gehan-Breslow-Wilcoxon p =0.038 tests were performed in GraphPad Prism 5 with 95#cod#x00025; CI of 0.7638-1.489 for ratios of survival. null,null,0(0),null-null. Doi:10.14336/AD.2017.0110